UNIGE document Scientific Article
previous document  unige:42547  next document
add to browser collection

Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy

Spinella, Giovanni
Bertolotto, Maria
Pane, Bianca
Pende, Aldo
show hidden authors show all authors [1 - 13]
Published in Thrombosis and haemostasis. 2013, vol. 109, no. 4, p. 706-15
Abstract We aimed at challenging the prognostic accuracies of myeloperoxidase (MPO) and antibodies anti-apolipoprotein A-1 (anti-apoA-1 IgG), alone or in combination, for major adverse cardiovascular events (MACE) prediction, one year after carotid endarterectomy (CEA). In this prospective single centre study, 178 patients undergoing elective CEA were included. Serum anti-apoA-1 IgG and MPO were assessed by enzyme-linked immunosorbent assay prior to the surgery. Post-hoc determination of the MPO cut-off was performed by receiver operating characteristics (ROC) analyses. MACE was defined by the occurrence of fatal or non-fatal acute coronary syndromes or stroke during one year follow-up. Prognostic accuracy of anti-apoA-1 IgG was assessed by ROC curve analyses, survival analyses and reclassification statistics. During follow-up, 5% (9/178) of patients presented a MACE, and 29% (52/178) were positive for anti-apoA-1 IgG. Patients with MACE had higher median MPO and anti-apoA-1 IgG levels at admission (p=0.01), but no difference for the 10-year global Framingham risk score (FRS) was observed (p=0.22). ROC analyses indicated that both MPO and anti-apoA-1 IgG were significant predictors of subsequent MACE (area under the curve [AUC]: 0.75, 95% confidence interval [95%CI]: 0.61-0.89, p=0.01; and 0.74, 95%CI: 0.59-90; p=0.01), but combining anti-apoA-1 IgG positivity and MPO>857 ng/ml displayed the best predictive accuracy (AUC: 0.78, 95%CI: 0.65-0.91; p=0.007). It was associated with a poorer MACE-free survival (98.2% vs. 57.1%; p<0.001, LogRank), with a positive likelihood ratio of 13.67, and provided incremental predictive ability over FRS. In conclusion, combining the assessment of anti-apoA-1 IgG and MPO appears as a promising risk stratification tool in patients with severe carotid stenosis.
Keywords Acute Coronary Syndrome/blood/etiology/immunology/mortalityAgedAged, 80 and overApolipoprotein A-I/immunologyArea Under CurveAutoantibodies/bloodBiological Markers/bloodC-Reactive Protein/analysisCarotid Stenosis/blood/diagnosis/immunology/mortality/surgeryEndarterectomy, Carotid/adverse effects/mortalityFemaleHumansKaplan-Meier EstimateLikelihood FunctionsLogistic ModelsMaleMiddle AgedOdds RatioPeroxidase/bloodProspective StudiesROC CurveRisk FactorsSeverity of Illness IndexStroke/blood/etiology/immunology/mortalitySwitzerlandTime FactorsTreatment Outcome
PMID: 23364307
Full text
Article (Published version) (194 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research groups Chimie et protéomique clinique (270)
Epidémiologie clinique (115)
Etude de l'activation des monocytes/macrophages et des polynucléaires neutrophiles (779)
L'athérosclérose et ses complications cliniques (591)
(ISO format)
VUILLEUMIER, Nicolas et al. Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy. In: Thrombosis and haemostasis, 2013, vol. 109, n° 4, p. 706-15. doi: 10.1160/TH12-10-0714 https://archive-ouverte.unige.ch/unige:42547

553 hits

1 download


Deposited on : 2014-12-05

Export document
Format :
Citation style :